Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study

LR Vaart,A Vollebregt,AL Milani,AL Lagro‐Janssen,RG Duijnhoven,J‐PWR Roovers,CH Vaart
DOI: https://doi.org/10.1111/1471-0528.16950
2021-10-28
Abstract:ObjectiveTo compare the 24-months efficacy of pessary or surgery as primary treatment for symptomatic pelvic organ prolapse (POP). DesignMulticenter prospective comparative cohort study. SettingTwenty-two Dutch hospitals. Study populationWomen referred with symptomatic POP stage ≥ 2 and moderate to severe POP symptoms. MethodsThe primary outcome was subjective improvement at 24-months follow-up according to the Patient Global Impression of Improvement (PGI-I) scale. Secondary outcomes included improvement in prolapse-related symptoms measured with the Pelvic Floor Distress Inventory (PFDI-20), improvement in subjective severeness of symptoms according to the Patient Global Impression of Severity (PGI-S) scale and cross-over between therapies. The primary safety outcome was the occurrence of adverse events. Main outcome measurementPGI-I at 24-months. ResultsWe included 539 women, 335 (62.2%) in the pessary arm and 204 (37.8%) in the surgery arm. After 24-months, subjective improvement was reported by 134 (83.8%) women in the surgery group as compared to 180 (74.4%) in the pessary group (risk difference 9.4%; 95% confidence-interval, 1.4 – 17.3; p<0.01). Seventy-nine (23.6%) women switched from pessary to surgery and 22 (10.8%) women in the surgery group underwent additional treatment. Both groups showed a significant reduction in bothersome POP symptoms (p≤0.01) and reduction in the perceived severity of symptoms (p≤0.001) compared to baseline. ConclusionSignificantly more women in the surgery group reported subjective improvement after 24-months. Both therapies however, showed a clinically significant relieve of prolapse symptoms.
obstetrics & gynecology
What problem does this paper attempt to address?